Capsugel® DBcaps® capsules are available in 8 sizes in gelatin and 3 sizes in hypromellose (HPMC). Our broad offer helps address the bioavailability and formulation challenges of oral solid dosage forms that need to be blinded for clinical trials. HPMC provides an excellent solution for hygroscopic filling as well as a dissolution performance that is maintained with formulations usually prone to promote cross-linking with gelatin.
Yes, the extended cap length of Capsugel® DBcaps® capsules completely covers the side wall of the capsule body, making it virtually impossible to open the capsule without causing visible damage. A dual locking ring design provides a full-circumference, leak-free closure.
Capsugel® DBcaps® capsules can be filled on most automatic and semi-automatic capsule filling machines, as well as on selected manual filling machines. For your convenience, the Lonza Engine™ equipment portfolio contains options for efficient over-encapsulation manufacturing of clinical batches.
Capsugel® DBcaps® are uniquely designed for double-blind clinical trials. Capsugel® DBcaps® capsules are shorter than standard size capsules, making them easier to swallow.
Capsugel® DBcaps® capsules can be ordered in any quantity and are also available in a convenient CapsuleCaddy™ Container, perfect for clinical trial batches and R&D projects.
Capsugel® DBcaps® are uniquely designed for double-blind clinical trials. Capsugel® DBcaps® are available in 8 sizes in gelatin and 3 sizes in hypromellose (HPMC), these sizes allow to encapsulate up to 90% of the most common tableted drugs.